相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Age and Genetics How Do Prognostic Factors at Diagnosis Explain Disparities in Acute Myeloid Leukemia?
Manali I. Patel et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann et al.
BLOOD (2012)
Understanding disparities in leukemia: a national study
M. I. Patel et al.
CANCER CAUSES & CONTROL (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Effects of Poverty and Race on Outcomes in Acute Myeloid Leukemia
Margaret M. Byrne et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia
S. Schnittger et al.
LEUKEMIA (2011)
Strong Maternal Khoisan Contribution to the South African Coloured Population: A Case of Gender-Biased Admixture
Lluis Quintana-Murci et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway
Youngil Koh et al.
ANNALS OF HEMATOLOGY (2009)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
Claudia Haferlach et al.
BLOOD (2009)
Delayed consultation among pulmonary tuberculosis patients: a cross sectional study of 10 DOTS districts of Ethiopia
Mengiste M. Mesfin et al.
BMC PUBLIC HEALTH (2009)
A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
Qin Huang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Low Frequency and Variability of FLT3 Mutations in Korean Patients with Acute Myeloid Leukemia
Soo-Mee Bang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient population
Rikio Suzuki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia
Michela Palmisano et al.
HAEMATOLOGICA (2007)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials
RE Gale et al.
BLOOD (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia
MA Sekeres et al.
BLOOD (2004)
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia
S Bhatia et al.
BLOOD (2002)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
分享论文
